KYIV. April 13 (Interfax-Ukraine) – Arterium Corporation (Kyiv) has launched a production line for infusion solutions at the facilities of PJSC Galychpharm (Lviv).
The corporation told Interfax-Ukraine that this is the first infusion line opened by the corporation.
Galychpharm received a license to produce infusions in December 2015, while in March 2016 it produced the first batch of solutions.
Earlier infusions under the Arterium brand were manufactured on a contract basis.
“With the new line for production of infusion solutions Arterium will strengthen its market position in the hospital segment, the segment of antibacterial drugs, and plans to occupy a significant market share in the infusion medicines market in Ukraine,” the corporation said.
As reported, the shareholders of PJSC Galychpharm at a general meeting on February 23, 2016 decided to place 7.093 million shares worth UAH 63.833 million.
